LENZ Therapeutics and Lunatus Marketing & Consulting FZCO recently announced an exclusive agreement for Lunatus to register and commercialize VIZZ, an FDA-approved aceclidine-based eye drop for ...
Meet Andrej Karpathy: OpenAI co-founder who coined 'vibe coding' says he's never felt more behind as a programmer (image YouTube) Artificial intelligence is changing the world faster than ever, and ...
Tesla's former AI director, Andrej Karpathy, warns software engineers face an unprecedented challenge as AI reshapes coding. He admits feeling behind, highlighting the need to master a new ...
The When Calls the Heart universe is getting a little bit bigger. On Friday, Hallmark announced that a prequel to the long-running series will debut exclusively on Hallmark+ in March 2026. Hope Valley ...
Decoder is now a video podcast. We’re very excited to announce that Decoder is now officially on YouTube. So if you prefer to watch and not just listen to your podcasts, you can head over to ...
Credit: Lenz Therapeutics. Vizz eye drops contain a cholinergic muscarinic agonist that causes contraction of the iris sphincter muscle, resulting in a pinhole effect that extends focus depth to ...
Caroline Lenz McClure passed away peacefully in Stockton on September 8, 2025. Caroline was a Stocktonian and member of a pioneer agricultural family. She was the daughter of Howard Oliver Lenz and ...
Have computer programmers innovated themselves out of a job? That’s the fear driving theories that AI will remove the need for humans who can write computer code. Today's most sophisticated large ...
Since 2018, Slate critic Willa Paskin has explored bizarre and delightful cultural phenomena from “Baby Shark” to Chuck E. Cheese to try to understand what makes people obsessed with arbitrary ...
iHeartMedia has named Dan Lenz its market president for Milwaukee. He’ll be responsible for all of the cluster’s operations, ranging from sales to programming. For Lenz, the move is a promotion, as he ...
Shares of LENZ Therapeutics, Inc. (LENZ) have gained 17% over the past four weeks to close the last trading session at $33.73, but there could still be a solid upside left in the stock if short-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results